Deep Venous Thrombosis
Lisa Duffett
Abstract
Venous thromboembolism (VTE) is the third most common cardiovascular disorder, affecting up to 5% of the population. VTE commonly manifests as lower-extremity deep venous thrombosis (DVT) or pulmonary embolism. Half of these events are associated with a transient risk factor and may be preventable with prophylaxis. Direct oral anticoagulants are effective and safe and carry a lower risk for bleeding than vitamin K antagonists. Many patients with VTE will have a chronic disease requiring long-term anticoagulation. Postthrombotic syndrome affects 25% to 40% of patients with DVT and significantly impacts function and quality of life.
Topics & Concepts
MedicineVenous thrombosisPulmonary embolismThrombosisVenous thromboembolismMajor bleedingPopulationRisk factorVitamin kIntensive care medicineDeep veinInternal medicineSurgeryAtrial fibrillationEnvironmental healthVenous Thromboembolism Diagnosis and ManagementAtrial Fibrillation Management and OutcomesBlood Coagulation and Thrombosis Mechanisms